H., Sakhvidi, Z., Dadvand, P
When the Breakthrough Obesity G-Agonist Drugs Exceed Expectations The expanding GLP-1 family of drugs and their expanded potential use cases Back last December I wrote about the The New Obesity Breakthrough Drugs, and specifically the striking results in randomized trials for semaglutide (Wegovy) and tirzepatide (Mounjaro) for weight loss, their putative mechanism(s), while also emphasizing their very high cost, lack of plan for successful weaning, and exacerbation of health inequities
The most common side effect of B12 injections is irritation at the injection site, and injections are typically administered intramuscularly or subcutaneously. Less common side effects may include headache, nausea, diarrhea, itching, or a brief feeling of lightheadedness after the injection
Regarding the central nervous system (CNS), the ascorbate located in the cerebrospinal fluid diffuses freely into the extracellular space of neurons and glia, where it is captured by both cell types via SVCT2 (except for astrocytes
When you eat a large cheeseburger or cream-based pasta shortly after taking semaglutide, the combination of delayed emptying and fat digestion amplifies nausea signals
This polyspecificity distinguishes Melanotan-2 from the next generation of analogs:PT-141 / bremelanotide is MC4R preferential, afamelanotide (Scenesse) is MC1R selective